LFMD

LifeMD, Inc. (LFMD) SWOT Analysis Analysis (2026)

Invetso Score: 3.7/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 5.8 (Moderate)

Negative cash conversion cycle of -172 days indicates LFMD collects cash far faster than peers, supporting liquidity and working-capital efficiency despite weak profitability.

Debt-to-equity of 0.76 is moderate versus highly levered healthcare peers, limiting balance-sheet strain relative to more indebted competitors.

Current ratio of 0.90 and quick ratio of 0.84 show near-term liquidity is slightly below one times current liabilities, reducing resilience versus stronger subscale peers.

Weaknesses

Score:

ROIC of -136.8% signals severe value destruction and materially trails profitable peers, indicating the business model has not yet converted scale into durable returns.

Net debt to EBITDA of 1.45x is still a leverage burden, but it is materially lower than last month’s level and less constraining than before.

Liquidity is now below one times current liabilities, leaving LFMD less resilient than peers with stronger cash buffers and more headroom.

Opportunities

Score:

If LFMD sustains its unusually negative cash conversion cycle, it can fund growth internally more efficiently than peers that must tie up more working capital.

Any improvement in operating profitability would have outsized peer-relative impact because the current return base is deeply negative and therefore highly levered to margin gains.

Deleveraging from the current net debt burden could quickly improve competitive positioning versus peers with weaker balance sheets and higher financing costs.

Threats

Score:

High leverage leaves LFMD more exposed than peers to interest-rate pressure, covenant risk, and tighter capital markets if operating performance remains uneven.

Persistently negative ROIC increases the risk that competitors with superior economics outinvest LFMD, widening the gap in scale, service breadth, and pricing power.

Thin liquidity relative to obligations raises execution risk versus peers with stronger current ratios, especially if reimbursement or demand conditions soften.

Overall Score

Score:

LFMD’s peer positioning remains constrained by deeply negative returns and still-elevated leverage, while its working-capital efficiency provides only a partial offset.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on LifeMD, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →